Skyline Medical Announces Corporate Name Change to Precision Therapeutics

Skyline Medical (NASDAQ:SKLN) today announced it will change its name to Precision Therapeutics, effective February 1, 2018. The new name has been chosen to better reflect the Company’s new strategic focus on applying artificial intelligence to precision medicine and drug discovery and marks a new chapter of the Company’s growth.
As quoted in the press release:

In addition to the new corporate name, the Company will change its ticker symbol on NASDAQ to ‘AIPT’. The Company will issue another press release in the near future announcing the date at which the new ticker symbol will take effect.
Precision Therapeutics mission is to positively improve the effectiveness of cancer therapy using the power of artificial intelligence (AI) applied to our rich data diseases data base. Through our venture with Helomics we control a diagnostic platform that generates rich molecular profiles and drug response data from the patient’s own tumor.

Click here to read the full press release.